Quick Answer
STANDARD BIOTOOLS INC. reported Diluted EPS of $0.20 per share (loss) for fiscal year 2025.
STANDARD BIOTOOLS INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.20 | +61.5% |
| 2024 | -$0.52 | +44.7% |
| 2023 | -$0.94 | +61.3% |
| 2022 | -$2.43 | -211.5% |
| 2021 | -$0.78 | -5.4% |
| 2020 | -$0.74 | +23.7% |
| 2019 | -$0.97 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.09 | -28.6% | +0.0% |
| June 30, 2025 | -$0.09 | +25.0% | -28.6% |
| March 31, 2025 | -$0.07 | +74.1% | +0.0% |
| September 30, 2024 | -$0.07 | +74.1% | +41.7% |
| June 30, 2024 | -$0.12 | +45.5% | +55.6% |
| March 31, 2024 | -$0.27 | -28.6% | +0.0% |
| September 30, 2023 | -$0.27 | +27.0% | -22.7% |
| June 30, 2023 | -$0.22 | +73.2% | -4.8% |
- STANDARD BIOTOOLS INC. showed an increase of +61.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, STANDARD BIOTOOLS INC.’s diluted eps has grown by 79.4% (from $0.97 per share (loss) to $0.20 per share (loss)).
- The most recent figure is from STANDARD BIOTOOLS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: